PRESS RELEASE published on 01/16/2025 at 07:00, 1 year 4 months ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Innate Pharma releases shares and voting rights update as of December 31, 2024, in compliance with regulations. Learn more about the global biotech company's innovative immunotherapies for cancer patients Voting Rights Shares Biotechnology Immunotherapy Innate Pharma
BRIEF published on 12/20/2024 at 07:05, 1 year 5 months ago Innate Pharma à la 43ème J.P. Morgan Healthcare Conference Investisseurs Présentation En Direct Immunothérapie Innate Pharma J.P. Morgan Conference
BRIEF published on 12/20/2024 at 07:05, 1 year 5 months ago Innate Pharma at the 43rd JP Morgan Healthcare Conference Investors Immunotherapy Innate Pharma JP Morgan Conference Live Presentation
PRESS RELEASE published on 12/20/2024 at 07:00, 1 year 5 months ago Informations privilégiées / Autres communiqués Innate Pharma annonce sa participation à la 43ème J.P. Morgan Healthcare Conference avec présentations de ses dirigeants. Focus sur les traitements d'immunothérapies contre le cancer Cancer Innate Pharma Biotechnologies Immunothérapies J.P. Morgan Healthcare Conference
PRESS RELEASE published on 12/20/2024 at 07:00, 1 year 5 months ago Inside Information / Other news releases Innate Pharma to participate in the 43rd Annual J.P. Morgan Healthcare Conference with CEO Jonathan Dickinson and other executives presenting. Company focuses on developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients J.P. Morgan Healthcare Conference
BRIEF published on 12/06/2024 at 07:05, 1 year 5 months ago Innate Pharma : Investissement de 7,9 millions de dollars pour IPH6501 Investissement Essai Clinique Innate Pharma Lymphome Folliculaire IPH6501
BRIEF published on 12/06/2024 at 07:05, 1 year 5 months ago Innate Pharma: Investment of 7.9 million dollars for IPH6501 Investment Clinical Trial Innate Pharma IPH6501 Follicular Lymphoma
PRESS RELEASE published on 12/06/2024 at 07:00, 1 year 5 months ago Informations privilégiées / Autres communiqués Innate Pharma et l'Institut d'Innovation pour le Lymphome Folliculaire (IFLI) signent un accord d'investissement jusqu'à 7,9 millions de dollars pour le développement d'IPH6501 dans le lymphome folliculaire Investissement Innate Pharma Lymphome Folliculaire IPH6501 IFLI
BRIEF published on 11/20/2024 at 07:05, 1 year 6 months ago Innate Pharma dévoile son calendrier financier pour 2025 Résultats Annuels Innate Pharma Calendrier Financier 2025 Assemblées Et Publications Cotisation Euronext Et Nasdaq
BRIEF published on 11/20/2024 at 07:05, 1 year 6 months ago Innate Pharma unveils its financial calendar for 2025 Annual Results Innate Pharma Financial Calendar 2025 Assemblies And Publications Euronext And Nasdaq Contribution
Published on 05/28/2026 at 10:30, 1 hour 26 minutes ago Caldwell Strengthens Financial Services and Fintech Capabilities with Addition of Alex Langridge in London
Published on 05/28/2026 at 10:10, 1 hour 46 minutes ago Powering Macau's Smart Future with AI - MACAU Pass and Ant Bank (Macao) Partner with Alibaba Ecosystem to Showcase Smart City Vision at BEYOND Expo
Published on 05/28/2026 at 09:05, 2 hours 51 minutes ago Tocvan Intersects Three New Gold-Silver Zones at Gran Pilar Project Exploration Drilling; Provides Pilot Mine Development Update
Published on 05/28/2026 at 09:01, 2 hours 55 minutes ago Discovery Energy Metals Corp. Mobilizes Crews for Surface Sampling Program at Crystal Lake Cu-Mo Project, British Columbia
Published on 05/28/2026 at 09:00, 2 hours 56 minutes ago Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th
Published on 05/28/2026 at 11:38, 17 minutes ago EQS-Adhoc: Energiekontor AG: Energiekontor AG resolves to buy back shares
Published on 05/28/2026 at 11:05, 50 minutes ago Omdia Q1 2026: Hisense Strengthens Global Leadership in 100-inch+ TVs
Published on 05/28/2026 at 11:00, 56 minutes ago ABB Ltd: ABB share buybacks - May 21, 2026 – May 27, 2026
Published on 05/28/2026 at 10:10, 1 hour 45 minutes ago SMT Scharf AG is successfully pursuing its strategy in the field of electric mobility
Published on 05/28/2026 at 10:10, 1 hour 45 minutes ago Huawei Named a Leader in the 2026 Gartner® Magic Quadrant™ for Enterprise Wired and Wireless LAN Infrastructure for the Fourth Year in a Row
Published on 05/28/2026 at 10:30, 1 hour 26 minutes ago Recticel Group opgenomen in Financial Times-lijst van Europese Klimaatleiders
Published on 05/28/2026 at 10:30, 1 hour 26 minutes ago Recticel Group included in Top 100 Financial Times list of Europe’s Climate Leaders
Published on 05/28/2026 at 08:45, 3 hours 11 minutes ago Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/28/2026 at 08:45, 3 hours 11 minutes ago Nomination de Mikael Frenkian en qualité de Directeur Général de Baikowski
Published on 05/28/2026 at 08:30, 3 hours 26 minutes ago Cegedim Business Services renforce sa conformité et sa sécurité avec deux distinctions majeures
